Role of the inflammatory processes in metabolic diseases and associated complications. Papel de los procesos inflamatorios en las enfermedades metabólicas y sus complicaciones asociadas.

Datos básicos

Protocolo:
PI19/00169
EUDRACT:
NCT:
Centro:
HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
Año de incio:
2020
Año de finalización:
2022
PROYECTO DE INVESTIGACIÓN NACIONAL F.COMPETITIVA FIN. PUBLICA 159.720,00 €

Documentos

  • No hay documentos

Participantes

Grupos y Plataformas de I+D+i

Financiadores - Promotores

INSTITUTO SALUD CARLOS III

Resultados del Ensayo Clínico


Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance.

Taberner-Cortes, Alida; (...); Gonzalez-Navarro, Herminia

Article. 10.3390/ijms21239216. 2020


Dissecting Abdominal Aortic Aneurysm Is Aggravated by Genetic Inactivation of LIGHT (TNFSF14).

Herrero-Cervera, A; (...); Gonzalez-Navarro, H

Article. 10.3390/biomedicines9111518. 2021


Frailty Is Associated with Oxidative Stress in Older Patients with Type 2 Diabetes.

Alabadi, B; (...); Real, JT

Article. 10.3390/nu13113983. 2021


Impact of Cholesterol Metabolism in Immune Cell Function and Atherosclerosis.

Aguilar-Ballester, Maria; (...); Gonzalez-Navarro, Herminia

Article. 10.3390/nu12072021. 2020


LIGHT DEFICIENCY IN APOE-/- MICE AGGRAVATES ATHEROMA PLAQUE BY ENHANCING APOPTOSIS

Hurtado-Genovés, G; (...); González-Navarro, H

Meeting Abstract. 2024


LIGHT DEFICIENCY IN APOE-/- MICE INCREASES ATHEROMA PLAQUE VULNERABILITY BY MODULATING ARTERY TERTIARY LYMPHOID ORGANS

Genovés, GH; (...); González-Navarro, H

Meeting Abstract. 2022


Light deficiency in Apoe-/-mice increases atheroma plaque size and vulnerability by modulating local immunity.

Hurtado-Genovés, G; (...); González-Navarro, H

Article. 10.1016/j.bbadis.2024.167052. 2024

  • Open Access.

Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists.

Jimenez-Marti, Elena; (...); Gonzalez-Navarro, Herminia

Article. 10.3390/nu14183775. 2022


Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia.

Aguilar-Ballester, M; (...); Gonzalez-Navarro, H

Article. 10.3390/ijms22020660. 2021


Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice.

Taberner-Cortés A; (...); González-Navarro H

Article. 10.1016/j.jnutbio.2024.109711. 2024

  • Open Access.

Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin ? receptor and the tumor necrosis factor receptor

Martin-Vano, S; (...); Gonzalez-Navarro, H

Article. 10.1016/j.arteri.2022.05.003. 2023


Campos de Estudio

Compartir